Interleukin-17—Extended Features of a Key Player in Multiple Sclerosis

American Journal of Pathology - United States
doi 10.2353/ajpath.2008.070862
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Autonomic Nervous System: A Key Player in Prodromal Multiple Sclerosis?

Clinical Autonomic Research
MedicineEndocrineNeurologyAutonomic Systems
2020English

Clinical Association of Serum Interleukin-17 Levels in Systemic Sclerosis: Is Systemic Sclerosis a Th17 Disease?

Journal of Dermatological Science
DermatologyBiochemistryMolecular Biology
2008English

Clinical Features of Childhood Multiple Sclerosis

AAP Grand Rounds
2003English

Mast Cells: The Key to Multiple Sclerosis?

World Journal of Neuroscience
2014English

Multiple Sclerosis: Longitudinal Measurement of Interleukin-1 Receptor Antagonist.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1997English

Atg14: A Key Player in Orchestrating Autophagy

International Journal of Cell Biology
Cell Biology
2011English

ST6GAL1: A Key Player in Cancer (Review)

Oncology Letters
Cancer ResearchOncology
2019English

Interleukin-22 Is Increased in Multiple Sclerosis Patients and Targets Astrocytes

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2015English

Interleukin-17

General Internal Medicine and Clinical Innovations
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy